PCM
LUXAW

PenderFund Capital Management’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

PenderFund Capital Management’s Portfolio LUXAW Stock Details LUXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,633
Closed -$6K – 185
2022
Q3 		$6K Sell
30,633
-2,366
-7% -$335 ﹤0.01% 169
2022
Q2 		$6K Hold
32,999
– – ﹤0.01% 167
2022
Q1 		$17K Hold
32,999
– – ﹤0.01% 159
2021
Q4 		$35K Hold
32,999
– – 0.01% 138
2021
Q3 		$48K Hold
32,999
– – 0.01% 67
2021
Q2 		$54K Hold
32,999
– – 0.01% 69
2021
Q1 		$62K Buy
+32,999
New +$83.2K 0.02% 79

PenderFund Capital Management's LUXAW Position: Q4 2022 in Review

PenderFund Capital Management sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 30,633 shares — an estimated $6K sold.

PenderFund Capital Management first reported a position in LUXAW in Q1 2021 and held it in 7 quarters. The position peaked at $62K in Q1 2021. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

  • PenderFund Capital Management reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • PenderFund Capital Management sold 30,633 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $6K.
  • PenderFund Capital Management first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 7 quarters.
  • PenderFund Capital Management's Lux Health Tech Acquisition Corp. Warrants position peaked at $62K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on PenderFund Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.